title: In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
abstract: A global collection of Cladophialophora carrionii strains (n = 81) was tested against nine antifungal drugs. MIC90s of all strains were as follows in increasing order: itraconazole and posaconazole, 0.063 μg/ml; terbinafine, 0.125 μg/ml; isavuconazole and voriconazole, 0.25 μg/ml; caspofungin, 2 μg/ml; micafungin, 4 μg/ml; amphotericin B, 8 μg/ml; and fluconazole, 64 μg/ml.
authors: Shanghai Institute of Medical Mycology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
authors: S
authors: S
authors: Deng
authors: G S
authors: GS
authors: de Hoog
authors: H
authors: H
authors: Badali
authors: L
authors: L
authors: Yang
authors: M J
authors: MJ
authors: Najafzadeh
authors: B
authors: B
authors: Pan
authors: I
authors: I
authors: Curfs-Breuker
authors: J F
authors: JF
authors: Meis
authors: W
authors: W
authors: Liao
mesh_terms: D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D001203:Ascomycota / Q000187:drug effects* / Q000472:pathogenicity*; D000077336:Caspofungin; D002862:Chromoblastomycosis / Q000382:microbiology*; D054714:Echinocandins / Q000494:pharmacology; D055666:Lipopeptides / Q000494:pharmacology; D000077551:Micafungin; D008826:Microbial Sensitivity Tests; D009570:Nitriles / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D014230:Triazoles / Q000494:pharmacology; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D009570:Nitriles; D011725:Pyridines; D011743:Pyrimidines; D014230:Triazoles; C508735:isavuconazole; C101425:posaconazole; D000666:Amphotericin B; D000077336:Caspofungin; D065819:Voriconazole; D000077551:Micafungin
references: Med Mycol. 2013 Feb;51(2):170-7
references: 22734968
references: Int J Dermatol. 1997 Jan;36(1):29-33
references: 9071611
references: J Antimicrob Chemother. 2012 Mar;67(3):666-70
references: 22190608
references: J Am Acad Dermatol. 1983 Jan;8(1):1-16
references: 6826791
references: Persoonia. 2011 Dec;27:46-72
references: 22403476
references: Future Microbiol. 2008 Dec;3(6):603-15
references: 19072177
references: Ann N Y Acad Sci. 1950 Sep;50(10):1255-82
references: 14783318
references: Mycopathologia. 1998-1999;143(3):171-5
references: 10353215
references: Aust J Dermatol. 1957 Jun;4(1):23-7
references: 13471430
references: Med Mycol. 2009 Feb;47(1):35-40
references: 19115138
references: Emerg Infect Dis. 2011 Mar;17(3):464-9
references: 21392438
references: Antimicrob Agents Chemother. 2012 Nov;56(11):6044-7
references: 22948876
references: Med Mycol. 2009 Feb;47(1):3-15
references: 19085206
references: J Antimicrob Chemother. 2010 Jan;65(1):175-7
references: 19854862
references: Antimicrob Agents Chemother. 2010 Apr;54(4):1636-8
references: 20086140
references: J Clin Microbiol. 2010 Jul;48(7):2350-6
references: 20421439